Skip to main content
Publication date
2017 12 19
Authors
Stupp, R Taillibert, S Kanner, A Read, W Steinberg, DM Lhermitte, B Toms, S Idbaih, A Ahluwalia, MS Fink, K Di Meco, F Lieberman, F Zhu, JJ Stragliotto, G Tran, DD Brem, S Hottinger, AF Kirson, ED Lavy-Shahaf, G Weinberg, U Kim, CY Paek, SH Nicholas, G Burna, J Hirte, H Weller, M Palti, Y Hegi, M Ram, Z
Pubmed ID
29260225
Journal
JAMA
Doctype
Article
KI Connection
Låg
Mesh SV
Alkylerande cellgifter Dakarbazin Elektroterapi Glioblastom Kemoradioterapi Kvinnlig Manlig Medelålders personer Mitos Människa Sjukdomsfri överlevnad Underhållande kemoterapi Uppföljningsstudier Vuxna Äldre Överlevnadsanalys
Mesh EN
Antineoplastic Agents, Alkylating Chemoradiotherapy Dacarbazine Disease-Free Survival Electric Stimulation Therapy Follow-Up Studies Glioblastoma Maintenance Chemotherapy Mitosis Survival Analysis Temozolomide
First date
2017-12-31T10:44:08.787Z